Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | F2R | P25116 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MYC | P01106 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31607659 | 1.00 | NPC1 (0.36) | NPC1RAB9AKMT2AMEN1AHR | |
| SCHEMBL9152862 | 0.86 | NPC1 (0.41) | NPC1RAB9AKMT2AMEN1ALDH1A1 | |
| SCHEMBL8200612 | 0.86 | NPC1 (0.41) | NPC1RAB9AKMT2AMEN1ALDH1A1 | |
| SCHEMBL8200609 | 0.86 | NPC1 (0.41) | NPC1RAB9AKMT2AMEN1ALDH1A1 | |
| SCHEMBL7475004 | 0.82 | PTGS2 (0.42) | KMT2AMEN1ALDH1A1HPGDKDM4E | |
| SCHEMBL9315359 | 0.82 | KDR (0.37) | NPC1RAB9AKMT2AALDH1A1HPGD | |
| SCHEMBL27209009 | 0.82 | PTGS2 (0.42) | KMT2AMEN1ALDH1A1HPGDKDM4E | |
| SCHEMBL31607697 | 0.82 | PTGS2 (0.42) | KMT2AMEN1ALDH1A1HPGDKDM4E | |
| SCHEMBL31711603 | 0.82 | ESR1 (0.41) | NPC1RAB9AKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL7659208 | 0.82 | PTGS2 (0.42) | KMT2AMEN1ALDH1A1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608802-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS XV | BASF SE (DE) | 2025-09-03 | — | — | EP | disclosed |
| CN-120091993-A | Use of strobilurin type compounds for combating phytopathogenic fungi comprising the amino acid substitution F129L in the mitochondrial cytochrome b protein conferring resistance to Qo inhibitor XV | 巴斯夫欧洲公司 | 2025-06-03 | — | — | CN | disclosed |
| WO-2024088792-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS XV | BASF SE (DE) | 2024-05-02 | — | — | WO | disclosed |
| EP-4361126-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS XV | BASF SE (DE) | 2024-05-01 | — | — | EP | disclosed |